Weekly Injection Replaces Painful Daily Shots for Rare Genetic Disorder
30 Jan 2025
A groundbreaking study by researchers at Rutgers University has shown that a weekly injection of tirzepatide, a medication traditionally used to treat diabetes and obesity, could potentially replace the painful daily injections currently used to manage a rare genetic disorder known as congenital generalized lipodystrophy (CGL). CGL, a condition that...
Read More